In this study, we demonstrated that Dlg1 ablation in microglia remarkedly reversed microglial activation and depression-like behavior in mice induced by exposure to CRS, indicating a potential target to suppress microglial activation, limit neuroinflammation, and thereby ameliorate depression. Here, DLG1 is linked to depressive symptom measurement.